FDA clears STERILE SANTIS Pedicle Screw System for use

LANTERNA News >>

STERILE SANTIS PEDICLE SCREW SYSTEM RECEIVES FDA APPROVAL

Saint Gallen - March 30th. 2015 - Lanterna Medical Technologies GmbH.

Lanterna Medical Technologies, a medical device company focused on developing innovative, intuitive and cost effective solutions for the surgical treatment of human skeletal disease, announced today, that the company has received clearance from the FDA to market their SANTIS PEDICLE SCREW SYSTEM, sterile format, in the United States.

Mr. Horace Hale, President of Lanterna said:

"We  are excited about the prospects for this evolutionary improvement in our flagship product line.

Our new format will provide surgeons with the unprecedented ability to treat a wide range of patholoies, while offering unparalleled ease of use combined with total traceability, plus operational and logistical efficacies that will have a verifiably positive and meanigful impact on the profitability and day to day management of a busy spine treatment center.

 

We are absolutely thrilled to be able to add the sterile format of our SANTIS PEDICLE SCREW SYSTEM to our users in the United States.

SANTIS's unique packaging concept dovetails perfectly with our strategy of focusing on minimally disruptive approaches while providing solutions for the profitability and efficacy challenges healthcare providers face each and every day.

We have our sights set on making a positive and lasting impact on the delivery and outcomes of spine surgery globally. The approval of SANTIS in its revolutionary new format, will afford us the opportunity to also positively impact the logistical and financial outcomes of spine treatment centers worldwide.

I am confident and excited about our future prospects inthis arena of considerable opportunity."

 

Back